Vaccines that target cancer could be available before the end of the decade.
That's according to the couple who co-founded BioNTech, one of the companies at the centre of developing the COVID vaccines.
The mRNA technology used in those vaccines has been in the works for 20 years.
Professor at Cork University Hospital, Seamus O'Reilly explains:
"The vaccine works similar to how it works in patients with receiving the COVID vaccine. The vaccine will prime the body and respond to the abnormal proteins that might be present on a cancer cell."
